Tailor-made therapy of multi-resistant tuberculosis

Biting the bullet: Firearm ownership in persons with dementia
3 May 2021
Denmark drops J&J vaccine from COVID vaccination programme
3 May 2021

Tailor-made therapy of multi-resistant tuberculosis

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly. While other typical pathogens, such as pneumococcal and pseudomonads, can already be identified by their growth in the microbiological laboratory in the first 72 hours, several weeks usually pass before tuberculosis bacteria grow in the lab. Thus it often takes one to two months before the efficacy of individual medicines can be tested.

Comments are closed.